697 results on '"Yu, Lianbo"'
Search Results
2. Comparing Accuracy of Helicobacter pylori Identification Using Traditional Hematoxylin and Eosin–Stained Glass Slides With Digital Whole Slide Imaging
3. Expression Patterns of microRNAs and Associated Target Genes in Ulcerated Primary Cutaneous Melanoma
4. Surface Enhanced Raman Spectroscopy Combined With Multivariate Analysis for Fingerprinting Clinically Similar, Fibromyalgia and Long-COVID Syndromes
5. Influenza A virus modulates ACE2 expression and SARS-CoV-2 infectivity in human cardiomyocytes
6. Rethinking Lupus Nephritis Classification on a Molecular Level.
7. Metabolic fingerprinting for diagnosis of fibromyalgia and other rheumatologic disorders.
8. Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis
9. Preclinical evaluation of combination nemtabrutinib and venetoclax in chronic lymphocytic leukemia
10. HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia
11. METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm–Controlled Gene Expression in Mice
12. Characterization of inflammatory changes in the breast cancer associated adipose tissue and comparison to the unaffected contralateral breast
13. On the Scope of Liability for Negligence in Maritime Search and Rescue under the Background of the Amendment to the Maritime Code
14. 477 Evaluating the therapeutic efficacy of combination IL-12 and trabectedin for the treatment of triple negative breast cancer
15. Abstract P25: Identification of biological components and novel clinical subsets of NPM1-mutated AML using an integrated, multi-omics approach
16. HTLV-1 infected T cells cause bone loss via small extracellular vesicles
17. Stabilin receptors clear LPS and control systemic inflammation
18. An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits
19. Pan-cancer Landscape of Programmed Death Ligand-1 and Programmed Death Ligand-2 Structural Variations
20. Establishing a Case for Anti-complement Therapy in Membranous Nephropathy
21. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions
22. Surface-Enhanced Raman Spectroscopy Combined with Multivariate Analysis for Fingerprinting Clinically Similar Fibromyalgia and Long COVID Syndromes.
23. An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
24. ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis
25. Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA).
26. Abstract B111: Developing prognostic signatures (ep-Sigs) through epigenetic predictive markers in pancreatic ductal adenocarcinoma (PDA) – A pilot study based on The Cancer Genome Atlas (TCGA) data
27. Portable Mid-Infrared Spectroscopy Combined with Chemometrics to Diagnose Fibromyalgia and Other Rheumatologic Syndromes Using Rapid Volumetric Absorptive Microsampling
28. Figure S1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
29. FIGURE 1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
30. FIGURE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
31. FIGURE 4 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
32. TABLE 2 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
33. TABLE 3 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
34. FIGURE 2 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
35. FIGURE 5 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
36. Data from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
37. TABLE 1 from Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials
38. Early Diagnosis of Fibromyalgia Using Surface-Enhanced Raman Spectroscopy Combined with Chemometrics
39. SLKB: synthetic lethality knowledge base
40. Metabolic Fingerprinting for the Diagnosis of Clinically Similar Long COVID and Fibromyalgia Using a Portable FT-MIR Spectroscopic Combined with Chemometrics
41. Differential Expression and Diagnostic Value of MUC5AC Glycoforms in Pancreatic Ductal Adenocarcinoma
42. Comparing Accuracy of Helicobacter pylori Identification Using Traditional Hematoxylin and Eosin (H&E)-stained Glass Slides with Digital Whole Slide Imaging
43. Induction of innervation by encapsulated adipocytes with engineered vitamin A metabolism
44. An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck
45. Characterizing the function of EPB41L4A in the predisposition to papillary thyroid carcinoma
46. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus
47. Expression of microRNAs and their target genes in melanomas originating from gynecologic sites
48. HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development
49. Fluorescent nanodiamonds engage innate immune effector cells: A potential vehicle for targeted anti-tumor immunotherapy
50. Molecular imaging of the kidney in lupus nephritis to characterize response to treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.